Quinoline compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9822078
SERIAL NO

15121973

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to quinoline compounds as defined by Formula I below. Such quinoline compounds have been shown to inhibit the formation of amyloid deposits (e.g., amyloid oligomers, fibrils or plaques). Consequently, these compounds are suitable for treating a range of diseases and disorders in which amyloid deposits are implicated, such as type-2 diabetes and Alzheimer's disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OXFORD UNIVERSITY INNOVATION LIMITEDOXFORD OX2 0JB

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bataille, Carole Oxford, GB 3 0
Brennan, Méabh London, GB 1 0
Davies, Stephen Oxford, GB 58 849
Jean, Letitia Oxford, GB 1 0
Russell, Angela Oxford, GB 3 0
Vaux, David Oxford, GB 4 48
Wynne, Graham Oxford, GB 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 21, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 21, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00